These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17999841)

  • 21. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-eluting stents in percutaneous coronary intervention: a benefit-risk assessment.
    Byrne RA; Sarafoff N; Kastrati A; Schömig A
    Drug Saf; 2009; 32(9):749-70. PubMed ID: 19670915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of newer-generation drug-eluting with bare-metal stents in patients with acute ST-segment elevation myocardial infarction: a pooled analysis of the EXAMINATION (clinical Evaluation of the Xience-V stent in Acute Myocardial INfArcTION) and COMFORTABLE-AMI (Comparison of Biolimus Eluted From an Erodible Stent Coating With Bare Metal Stents in Acute ST-Elevation Myocardial Infarction) trials.
    Sabaté M; Räber L; Heg D; Brugaletta S; Kelbaek H; Cequier A; Ostojic M; Iñiguez A; Tüller D; Serra A; Baumbach A; von Birgelen C; Hernandez-Antolin R; Roffi M; Mainar V; Valgimigli M; Serruys PW; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2014 Jan; 7(1):55-63. PubMed ID: 24332419
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost effectiveness of sirolimus-eluting stents compared with bare metal stents in acute myocardial infarction: insights from the TYPHOON trial.
    Canoui-Poitrine F; Jeanblanc G; Alberti C; Armoogum P; Cebrian A; Carrié D; Henry P; Teiger E; Slama M; Spaulding C; Durand-Zaleski I
    Appl Health Econ Health Policy; 2009; 7(1):19-29. PubMed ID: 19558192
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug eluting versus bare metal stents for percutaneous coronary intervention of saphenous vein graft lesions: An updated meta-analysis of randomized controlled trials.
    Ha FJ; Nogic J; Montone RA; Cameron JD; Nerlekar N; Brown AJ
    Cardiovasc Revasc Med; 2018; 19(7 Pt B):837-844. PubMed ID: 29685385
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Role of Vascular Imaging in Guiding Routine Percutaneous Coronary Interventions: A Meta-Analysis of Bare Metal Stent and Drug-Eluting Stent Trials.
    Alsidawi S; Effat M; Rahman S; Abdallah M; Leesar M
    Cardiovasc Ther; 2015 Dec; 33(6):360-6. PubMed ID: 26363283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical outcomes with bioabsorbable polymer- versus durable polymer-based drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Smits PC; Kaiser C; D'Ascenzo F; Frati G; Mancone M; Genereux P; Stone GW
    J Am Coll Cardiol; 2014 Feb; 63(4):299-307. PubMed ID: 24211507
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical outcomes with drug-eluting and bare-metal stents in patients with ST-segment elevation myocardial infarction: evidence from a comprehensive network meta-analysis.
    Palmerini T; Biondi-Zoccai G; Della Riva D; Mariani A; Sabaté M; Valgimigli M; Frati G; Kedhi E; Smits PC; Kaiser C; Genereux P; Galatius S; Kirtane AJ; Stone GW
    J Am Coll Cardiol; 2013 Aug; 62(6):496-504. PubMed ID: 23747778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes following coronary drug-eluting- and bare-metal-stent implantation.
    Auer J; Leitner A; Berent R; Lamm G; Lassnig E; Krennmair G
    Atherosclerosis; 2010 Jun; 210(2):503-9. PubMed ID: 20060973
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-Eluting Stents Versus Bare-Metal Stents in Large Coronary Artery Revascularization: Systematic Review and Meta-Analysis.
    Changal KH; Mir T; Khan S; Nazir S; Elzanatey A; Meenakshisundaram C; Mubbasher S; Sheikh MA
    Cardiovasc Revasc Med; 2021 Feb; 23():42-49. PubMed ID: 32723603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Drug-Eluting Stents With Bare-Metal Stents for PCI of Saphenous Vein Graft Lesions: Systematic Review and Meta-Analysis.
    Mosleh W; Gandhi S; Elsiddig M; Schwalm JD; Farkouh ME
    J Invasive Cardiol; 2016 Dec; 28(12):E139-E169. PubMed ID: 27845875
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical outcomes of the Resolute zotarolimus-eluting stent in patients with in-stent restenosis: 2-year results from a pooled analysis.
    Richardt G; Leschke M; Abdel-Wahab M; Toelg R; El-Mawardy M; Serruys PW; Silber S; Windecker S; Belardi JA; Neumann FJ; Widimsky P; ;
    JACC Cardiovasc Interv; 2013 Sep; 6(9):905-13. PubMed ID: 23954063
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A systematic review and economic analysis of drug-eluting coronary stents available in Australia.
    Lord SJ; Howard K; Allen F; Marinovich L; Burgess DC; King R; Atherton JJ
    Med J Aust; 2005 Nov; 183(9):464-71. PubMed ID: 16274347
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Second generation drug-eluting stents versus bare-metal stents for percutaneous coronary intervention of the proximal left anterior descending artery: An analysis of the BASKET-PROVE I and II trials.
    Mangione FM; Biering-Sørensen T; Nochioka K; Jatene T; Silvestre OM; Hansen KW; Sørensen R; Jensen JS; Jorgensen PG; Jeger R; Kaiser C; Pfisterer M; Galatius S
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):867-873. PubMed ID: 28722266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cost-effectiveness of the Endeavor stent in de novo native coronary artery lesions updated with contemporary data.
    Remak E; Manson S; Hutton J; Brasseur P; Olivier E; Gershlick A
    EuroIntervention; 2010 Feb; 5(7):826-32. PubMed ID: 20142198
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cost-effectiveness of drug-eluting stents versus bare metal stents in clinical practice.
    Schafer PE; Sacrinty MT; Cohen DJ; Kutcher MA; Gandhi SK; Santos RM; Little WC; Applegate RJ
    Circ Cardiovasc Qual Outcomes; 2011 Jul; 4(4):408-15. PubMed ID: 21693724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Beneficial 2-years results of drug-eluting stents in saphenous vein graft lesions.
    Assali A; Raz Y; Vaknin-Assa H; Ben-Dor I; Brosh D; Teplitsky I; Fuchs S; Kornowski R
    EuroIntervention; 2008 May; 4(1):108-14. PubMed ID: 19112787
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and effectiveness of drug-eluting stents versus bare-metal stents in elderly patients with small coronary vessel disease.
    Puymirat E; Mangiacapra F; Peace A; Ntarladimas Y; Conte M; Bartunek J; Vanderheyden M; Wijns W; de Bruyne B; Barbato E
    Arch Cardiovasc Dis; 2013 Nov; 106(11):554-61. PubMed ID: 24231052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.